Lecture Title: Data-Driven Insights into the Development Trends and Prospects of Global Small Molecule Innovative Drugs and Our Exploration
Date and Time: October 25, 2023 (Wednesday), 10:00-11:30 AM
Location: Wang Changlai Building Multi-Function Hall, Medical School
Speaker: Professor Lu Tao
Speaker Biography:
Professor Lu Tao, Ph.D. supervisor in Medicinal Chemistry, named a Distinguished Teacher of Jiangsu Province, and former Vice President of China Pharmaceutical University. He currently serves as the Deputy Director of the National Steering Committee for Pharmaceutical Academic Degree Graduate Education, Chairman of the Drug Regulatory Talent Training Research Professional Committee under the China Drug Supervision and Management Research Association, and Vice President of the Regulatory Science Research Branch of the China Drug Supervision Research Association; member of the Jiangsu Provincial Degree Committee. He is the Executive Editor-in-Chief and Chair of the Editorial Board for "Progress in Pharmaceutical Sciences" and an editorial board member for the "Journal of China Pharmaceutical University" and the Associate Editor for Molecular Diversity.
His main research directions include: 1) Innovative drug discovery for major diseases; 2) New methods and strategies for drug design based on artificial intelligence and their application research; 3) Methodological studies of important chemical issues in innovative drug research. He has presided over and completed numerous national and provincial-level projects. Currently, he is working on two projects funded by the National Natural Science Foundation of China. An anti-tumor compound developed independently by his team was transferred to Shanghai Fosun Pharmaceutical Industry Co., Ltd. for a contract price of 150 million RMB. The compound is now undergoing Phase I clinical trials in the United States, Australia, and China, mainly for the treatment of Acute Myeloid Leukemia (AML). In November 2019, this drug was granted Orphan Drug Designation by the U.S. FDA. He has published over 130 high-level scientific research papers and has supervised 20 Ph.D. students and more than 130 master's students. He currently supervises 6 doctoral candidates and 25 master's students.
